Long-term Diet Pills Show Poor Performance
November 22nd, 2007 by colon.ddetox
The study, which looked at the long-term effectiveness of anti-obesity medications, found that three drugs recommended for long-term use - orlistat, sibutramine and rimonabant, reduced weight by less than 5kg (11 pounds). This equated to a loss of less than 5% of total body weight. Guidelines from the National Institute for Clinical Excellence recommend stopping the use of anti-obesity drugs if 5% of total body weight is not lost after three months.
Professor Raj Padwal and colleagues found orlistat reduced weight by 2.9kg, sibutramine by 4.2kg and rimonabant by 4.7kg. They also found that patients taking the weight loss pills were significantly more likely to achieve 5 — 10% weight loss, compared to those who took the placebo.
anty obesity medications, anty obesity drugs, orlistat, rimonabant, sibutramine, weight loss guidelines, weight loss pills
